Your browser doesn't support javascript.
loading
Interlaboratory Variability in the Madin-Darby Canine Kidney Cell Proteome.
Harwood, Matthew D; Zettl, Katharina; Weinheimer, Manuel; Pilla-Reddy, Venkatesh; Shen, Hong; Jacobs, Frank; Chu, Xiaoyan; Huth, Felix; Nakakariya, Masanori; Chothe, Paresh P; Neuhoff, Sibylle; Wisniewski, Jacek R.
Afiliação
  • Harwood MD; Certara UK Ltd (Simcyp Division), Sheffield S1 2BJ, U.K.
  • Zettl K; Biochemical Proteomics Group, Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried 82152, Germany.
  • Weinheimer M; Quantitative, Translational & ADME Sciences, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen 67061, Germany.
  • Pilla-Reddy V; Clinical Pharmacology and Quantitative Pharmacology, Vaccines and Immunotherapies, Neuroscience and Clinical Immunogenicity, AstraZeneca, Cambridge CB2 0AA, U.K.
  • Shen H; Drug Metabolism and Pharmacokinetics, Bristol Myers Squibb, Princeton, New Jersey 08543, United States.
  • Jacobs F; Preclinical Sciences Translational Safety, Janssen Pharmaceutical Companies of Johnson & Johnson, Beerse 2340, Belgium.
  • Chu X; ADME and Discovery Toxicity, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
  • Huth F; Novartis Institutes for BioMedical Research, Basel 4056, Switzerland.
  • Nakakariya M; Global Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc. (TDCA), 9625 Towne Centre Drive, San Diego, California 92121, United States.
  • Chothe PP; Drug Metabolism and Pharmacokinetics, Vertex Pharmaceuticals, Boston, Massachusetts 02210, United States.
  • Neuhoff S; Certara UK Ltd (Simcyp Division), Sheffield S1 2BJ, U.K.
  • Wisniewski JR; Biochemical Proteomics Group, Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried 82152, Germany.
Mol Pharm ; 20(7): 3505-3518, 2023 07 03.
Article em En | MEDLINE | ID: mdl-37283406
ABSTRACT
Madin-Darby canine kidney (MDCK) cells are widely used to study epithelial cell functionality. Their low endogenous drug transporter protein levels make them an amenable system to investigate transepithelial permeation and drug transporter protein activity after their transfection. MDCK cells display diverse phenotypic traits, and as such, laboratory-to-laboratory variability in drug permeability assessments is observed. Consequently, in vitro-in vivo extrapolation (IVIVE) approaches using permeability and/or transporter activity data require calibration. A comprehensive proteomic quantification of 11 filter-grown parental or mock-transfected MDCK monolayers from 8 different pharmaceutical laboratories using the total protein approach (TPA) is provided. The TPA enables estimations of key morphometric parameters such as monolayer cellularity and volume. Overall, metabolic liability to xenobiotics is likely to be limited for MDCK cells due to the low expression of required enzymes. SLC16A1 (MCT1) was the highest abundant SLC transporter linked to xenobiotic activity, while ABCC4 (MRP4) was the highest abundant ABC transporter. Our data supports existing findings that claudin-2 levels may be linked to tight junction modulation, thus impacting trans-epithelial resistance. This unique database provides data on more than 8000 protein copy numbers and concentrations, thus allowing an in-depth appraisal of the control monolayers used in each laboratory.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteoma / Proteômica Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteoma / Proteômica Idioma: En Ano de publicação: 2023 Tipo de documento: Article